Publication:


abstract

Mutation of the neurexin1-gene, NRXN1, interrupting the expression of neurexin1 has been associated with schizophrenia, autism, and intellectual disability. We have identified a family multiply affected with psychiatric, neurological, and somatic disorders along with an intricate co-segregation of NRXN1 mutations. The proband suffered from autism, mental retardation, and epilepsy and on genotyping it was revealed that he carried a compound heterozygous mutation in the NRXN1 consisting of a 451 kb deletion, affecting the promoter and first introns in addition to a point mutation, predicted to be deleterious to NRXN1. The deletion was passed on from the patient's mother who was clinically characterized by sub-diagnostic autistic traits in addition to type 1 diabetes mellitus. The point mutation was subsequently found in the patient's brother, suffering from a psychotic disorder, which implies that the point mutation was inherited from the deceased father, who was diagnosed with schizophrenia. The observations suggest a possible gene-dose effect of NRXN1 mutations on type and severity of mental illness and support the notion that the penetrance and pleiotropy of pathogenic CNVs in general are determined by additional genetic variants in the genome. Finally the findings also propose a linkage of NRXN1 neurobiology to epilepsy and possibly to type 1 diabetes.

Copyright © 2012 Wiley Periodicals, Inc.

Related Articles
Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
BMC Med Genet. 2011
Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
Gregor A, Albrecht B, Bader I, Bijlsma EK, Ekici AB, Engels H, Hackmann K, Horn D, Hoyer J, Klapecki J, et al. BMC Med Genet. 2011 Aug 9; 12:106. Epub 2011 Aug 9.
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
Hum Genet. 2011
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
Gauthier J, Siddiqui TJ, Huashan P, Yokomaku D, Hamdan FF, Champagne N, Lapointe M, Spiegelman D, Noreau A, Lafrenière RG, et al. Hum Genet. 2011 Oct; 130(4):563-73. Epub 2011 Mar 22.
Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.
Am J Med Genet B Neuropsychiat...
Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.
Ching MS, Shen Y, Tan WH, Jeste SS, Morrow EM, Chen X, Mukaddes NM, Yoo SY, Hanson E, Hundley R, et al. Am J Med Genet B Neuropsychiatr Genet. 2010 Jun 5; 153B(4):937-47.
Review The genetics of autism.
Pediatrics. 2004
Review The genetics of autism.
Muhle R, Trentacoste SV, Rapin I. Pediatrics. 2004 May; 113(5):e472-86.
Review Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.
Cytogenet Genome Res. 2011
Review Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.
Hochstenbach R, Buizer-Voskamp JE, Vorstman JA, Ophoff RA. Cytogenet Genome Res. 2011; 135(3-4):174-202. Epub 2011 Nov 2.
Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci.
Mol Autism. 2012
Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci.
Hedges DJ, Hamilton-Nelson KL, Sacharow SJ, Nations L, Beecham GW, Kozhekbaeva ZM, Butler BL, Cukier HN, Whitehead PL, Ma D, et al. Mol Autism. 2012 Apr 2; 3:2. Epub 2012 Apr 2.